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health-related quality of life (HRQOL) may be an impor-
tant factor in encouraging smokers to reduce or quit
smoking. This study examines the relationship between
smoking status and HRQOL using self-reported data
from the 2001 Behavioral Risk Factor Surveillance
System (BRFSS) for West Virginia. METHODS: Respon-
dents (N = 3093) were classiﬁed as current smokers, 
ex-smokers or non-smokers based on whether they had
smoked at least 100 cigarettes in their entire lifetime 
and whether they currently smoke. HRQOL data were
obtained from the health status section (4 items) of the
BRFSS survey. Logistic regression models adjusted for
demographics, obesity, and presence of comorbidities
(arthritis, asthma, cardiovascular disease and diabetes)
were conducted for the four HRQOL items. RESULTS:
Compared with current smokers, non-smokers had higher
odds of reporting good, very good or excellent general
health (OR = 1.80, 95% CI = 1.34 - 2.34) and lower
odds of reporting 14 or more days of poor physical health
during the previous 30 days (OR = 0.57, 95% CI = 0.43
- 0.76). The odds of reporting 14 or more days of poor
mental health during the previous 30 days were lower for
non-smokers (OR = 0.48, 95% CI = 0.36 - 0.63) and 
ex-smokers (OR = 0.68, 95% CI = 0.50 - 0.92) compared
to current smokers. Similarly, the odds of reporting 14 or
more days of activity limitations during the previous 30
days were lower for non-smokers (OR = 0.39, 95% CI =
0.27 - 0.55) and for ex-smokers (OR = 0.62, 95% CI =
0.43 - 0.89) compared to current smokers. In addition,
age, income and presence of comorbidities signiﬁcantly
explained variation in HRQOL. CONCLUSIONS: The
study results show a signiﬁcant relationship between
smoking status and self-reported HRQOL. Particularly,
ﬁndings that ex-smokers have reported fewer days of
poor mental health and activity limitations compared to
current smokers, may ﬁnd important implications in
designing smoking cessation programs.
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SUICIDE ATTEMPTS BY ADOLESCENTS:
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OBJECTIVE: Suicide by teenagers is an alarming
problem that is on the rise. This study examines admis-
sions resulting from a suicide attempt by an adolescent
and estimates the resulting cost of hospital care.
METHODS: Cases of adolescent, deﬁned as age 10
through 19 years, suicide attempts were identiﬁed using
ICD-9 diagnosis, and the corresponding E codes. Inpa-
tient hospital costs were developed based on 1999 dis-
charge data from four US states. Cost estimates include
all accommodation, ancillary and physician services.
National physician fee schedules were also used. Cost
estimates are reported in 2002 US$. Charges were
adjusted by means of a cost-to-charge ratio. RESULTS:
Of the 4067 suicide attempts identiﬁed, 70% were
female. The mean age for adolescents in this group was
16.5 years. A drug overdose was listed as the principal
diagnosis in 66% of cases. Almost three-quarters of cases
were admitted via the emergency room and 37% had a
stay in a special care unit. The mean length of stay was
3.4 days (range: 1–143) and the mean cost per stay was
$5,680 (range: $407–$385,132). The inpatient case fatal-
ity rate was less than 1%. Of those discharged alive, 26%
were transferred to either a mental health or residential
care facility, and 5.6% were readmitted within 12 months
due to another attempt. The majority (80%) of those
readmitted had one additional stay for another attempt
(range: 1–3) and all survived these subsequent attempts.
Managed care organizations were the largest single payer
group, responsible for half of the cases. CONCLUSIONS:
The overwhelming majority of cases treated in this setting
survive the attempt. Suicide attempts by adolescents 
generate substantial costs. Costs related to acute hospital
treatment of clinical conditions resulting from a suicide
attempt are but one economic aspect of managing these
patients, as many require post-discharge health care 
services.
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OBJECTIVES: The objective of this study was to 
evaluate the effect of a 1-time, mailed intervention on
subsequent prescribing of antibiotics for initial episodes
of Acute Otitis Media (AOM). The intent was to alter
prescribing behavior in the direction of optimal treatment
guidelines. Past interventions mailed to prescribers have
had mixed results, and have rarely been assessed using
strong research designs. METHODS: A randomized con-
trolled trial was used. Physicians in the North Carolina
Medicaid Program with a lower prescribing rate of ﬁrst
line antibiotics for initial episodes of AOM than peers
during a prior 1-year period were randomized into inter-
vention (n = 413) and control (n = 375) groups. Cluster-
ing of prescribers by clinic and geographic area was done
to avoid contamination bias and statistical problems asso-
ciated with a lack of independence of observations. The
mailed intervention package contained a prescriber-
speciﬁc proﬁle detailing each physician’s prescribing 
rate compared to peers for initial episodes of AOM and 
prescription cost data, guidelines for the use of antibiotics
for AOM, a self assessment form with an opportunity 
to earn CME credits, and a prescriber response form. 
Prescribing was monitored for 21 months of baseline and
9 months of follow-up. RESULTS: On average across all
physicians in intervention group, prescribing of ﬁrst line
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antibiotics increased from 53% to 56% at initial visits for
AOM. The increase was statistically signiﬁcant compared
to controls. The increase was greatest among emergency
room physicians, while remaining unchanged among
family medicine physicians. Characteristics of prescribers
who were most responsive to the intervention were
further described using multivariate analyses. CONCLU-
SIONS: The intervention achieved a statistically signiﬁ-
cant increase of prescription rate of ﬁrst line antibiotics
in the treatment of initial visits for AOM in children after
a single mailing, but the magnitude of change was not
large.
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OBJECTIVES: To determine the feasibility, validity 
and reliability of KINDL in an Asian school-based
sample. Introduction: KINDL-Kid and KINDL-Kiddo
have been culturally adapted and tested in a sample of
diabetic and healthy children in Singapore with promis-
ing results. Testing of KINDL was extended to a school-
based sample more representative of the general children
population. METHODS: Invitations for participations
were sent to all schools in Singapore after permission was
obtained from the Ministry of Education. Students aged
8–16 years old from participating schools were randomly
selected. After the purpose of the study was explained,
the questionnaires were administered and the participants
were asked to complete the questionnaire without seeking
their friends’ opinions. The students were asked to report
if they had any of the chronic conditions such as asthma
and diabetes. RESULTS: A total of 328 participants 
completed KINDL-Kid (mean score: 68.3 ± 12.57%)
while 1026 completed KINDL-Kiddo (mean score: 59.3
± 11.64%). 25 KINDL-Kid and 56 KINDL-Kiddo par-
ticipants were asthmatics. Majority of participants in
both groups were Chinese (KINDL-Kid: 74.1%, KINDL-
Kiddo: 75.2%) and females (KINDL-Kid: 67.0%; and
KINDL-Kiddo: 71.5%). The reliability coefﬁcients (Cron-
bach’s alpha) ranged from 0.4040 to 0.7091 for KINDL-
Kid and 0.3971 to 0.8448 for KINDL-Kiddo. The ceiling
effect was signiﬁcant (>5.0%) in four KINDL-Kid sub-
scales but only one KINDL-Kiddo subscale, while signif-
icant ﬂooring effect was observed in one subscale of both
instruments. KINDL-Kiddo demonstrated discriminant
validity (Healthy vs. Self-reported asthmatics: 56.6 ±
11.92% vs. 51.3 ± 13.21%, p < 0.005) but not KINDL-
Kid (65.5 ± 12.76% vs.66.3 ± 12.71%; p = 0.768). 
CONCLUSION: The scale reliability obtained suggested
a need to re-evaluate the factor structures of KINDL. A
factor analysis may be warranted before KINDL is used
in Singapore on a large scale.
PD4
LONGITUDINAL EXAMINATION OF
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OBJECTIVE: The use of botulinum toxin type A (BTX)
in the management of spasticity in childhood CP is
increasing. Improvement of physical functioning has been
demonstrated in short-term clinical trials, but not in
prospective longitudinal studies. We examined both 
child physical functioning and parent-caregiver related
psychosocial outcomes related to this treatment in a lon-
gitudinal setting. METHODS: A prospective cohort study
with annual follow-ups for 2 years was conducted in 172
children with spastic type of cerebral palsy receiving Bot-
ulinum Toxin-A (BTX) injections for spasticity manage-
ment in a large academic medical center setting. A mixed
modeling procedure with baseline status confounder
adjustment was used to identify changes in both physical
functioning outcomes for the child (using the WEEFIM
measure) as well as quality of life of the parent caregiver
(using the Stein and Reissman Family Impact Scale) with
increasing utilization of BTX injections. RESULTS: Each
child received an average of 3 BTX injections each year
(range: 1–13). Baseline values of outcome variables indi-
cated poor physical functioning in children and signiﬁ-
cant quality of life burden on the parent caregiver. The
study found that each additional BTX injection adminis-
tration was associated with a 2.3% improvement in 
the WEEFIM, compared to average baseline score (p =
0.004). Similarly, the study found an improvement of 1%
in the parents overall perception of the severity of the
child’s condition Family Impact Scale with each addi-
tional BTX injection administration (p = 0.008). This
reduced perception of severity was in turn, associated
with a decreased family impact score. CONCLUSIONS:
These ﬁndings suggest that treatment with BTX injections
are associated with signiﬁcant improvements in both
physical functioning of the child with cerebral palsy as
well as the quality of life of the child’s parent caregiver.
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